INDGN vs SUVEN: Stock Comparison
INDEGENE is the larger company by market capitalisation. INDEGENE shows a higher ROE, a higher dividend yield and faster revenue growth, while SUVEN LIFE SCIENCES shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
INDGN leads 10; SUVEN leads 2 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | INDGN | SUVEN |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Research Analytics & Technology | Healthcare Research Analytics & Technology |
Price
| Metric | INDGN | SUVEN |
|---|---|---|
| Live Price | ₹592.1 | ₹335.45 |
| Day Change | -0.65% | -0.73% |
| Volume | 1.92 L | 2.71 L |
| 52-Week High | ₹615.5 | ₹403.35 |
| 52-Week Low | ₹414 | ₹124.11 |
| Distance from 52W High | -3.8% | -16.83% |
Valuation
| Metric | INDGN | SUVEN |
|---|---|---|
| Market Cap | ₹14,289 Cr | ₹9,486 Cr |
| P/E Ratio | 35.59x | 0x |
| P/B Ratio | 4.55x | 14.97x |
| EPS | ₹16.62 | ₹-0.61 |
| Book Value | ₹130.29 | ₹22.4 |
| Dividend Yield | 0.37% | 0% |
Growth
| Metric | INDGN | SUVEN |
|---|---|---|
| Revenue Growth (TTM YoY) | 32.8% | 3.6% |
| EPS Growth (TTM YoY) | -32.3% | 0% |
| Qtr Sales Growth | 212.03% | 0% |
| Qtr Profit Growth | 93.99% | 87.37% |
Profitability & Leverage
| Metric | INDGN | SUVEN |
|---|---|---|
| ROE | 12.78% | -46.73% |
| ROCE | 14.54% | -47.36% |
| Net Margin | 12.03% | -3,884.13% |
| Operating Margin | 15.5% | -3,881.91% |
| Debt to Equity | 0x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | INDGN | SUVEN |
|---|---|---|
| Promoter Holding | — | 65.47%▼ 4.61 pp |
| FII Holding | 9.91%▼ 0.36 pp | 0.48%▼ 0.09 pp |
| DII Holding | 8.74%▲ 0.44 pp | 2.73%▼ 0.2 pp |
| Public Holding | 81.34%▼ 0.1 pp | 31.32%▲ 4.89 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDEGENE and SUVEN LIFE SCIENCES.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.